Showing 621 - 640 results of 1,762 for search '(( 200 mg decrease ) OR ( 10 ((per decrease) OR (((nn decrease) OR (a decrease)))) ))*', query time: 0.22s Refine Results
  1. 621
  2. 622

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  3. 623
  4. 624

    Novel fluorinated surfactants for enhanced oil recovery in carbonate reservoirs by Al-Amodi, Adel O.

    Published 2016
    “…However, betaine‐based co‐surfactant reduced the IFT to 10−3 mN/m. An adsorption isotherm showed that the maximum adsorption of surfactant‐A was 1 mg per g of rock. …”
    Get full text
    Get full text
  5. 625

    Absorption of CO2 in aqueous blend of methyldiethanolamine and arginine by Talkhan, Ahmed Gomaa

    Published 2020
    “…The study was carried out at different mixing ratios of MDEA and Arg at a total concentration of 2 moles per litre. The CO2 partial pressure varied from about 10 to 100 kPa, and the temperature varied from 293 K to 323 K. …”
    Get full text
    Get full text
  6. 626
  7. 627
  8. 628
  9. 629

    Impaired Liver Size and Compromised Neurobehavioral Activity are Elicited by Chitosan Nanoparticles in the Zebrafish Embryo Model by Abou-Saleh, Haissam

    Published 2019
    “…Our data highlight the absence of both acute and teratogenic toxic effects of ChNPs (~100% survival rate) even at the higher concentration employed (200 mg/L). Although no single sign of cardiotoxicity was observed upon exposure to 200 mg/L of ChNPs, as judged by heartbeat rate, the corrected QT interval (QTc, which measures the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle), maximum cardiac arrest, and ejection fraction assays, the same dosage elicited the impairment of both liver size (decreased liver size, but without steatosis and lipid yolk retention) and neurobehavioral activity (increased movement under different light conditions). …”
    Get full text
    Get full text
  10. 630

    Synthesizing New Anodes From Qatalum's 1st Cut Spl by Hani Holozadah, Abdullah

    Published 2014
    “…This might result in extending the life time of the carbon anodes and decrease the number of carbon dioxide kilograms that are released per a ton of produced Al metal. …”
    Get full text
    Get full text
  11. 631
  12. 632
  13. 633
  14. 634
  15. 635
  16. 636

    Silymarin-albumin nanoplex: Preparation and its potential application as an antioxidant in nervous system in vitro and in vivo by Sohrabi M.J.

    Published 2019
    “…For in vivo experiments, rats were pre-treated with either silymarin or silymarin -HSA nanoplex (200mg/kg) orally for 3 days and at third day received LPS by IP at a dose of 0.5 mg/kg, 150 min before scarification followed by SOD and CAT activity assay. …”
    Get full text
    Get full text
  17. 637

    CLINICAL AND ECONOMIC IMPACT OF GENETIC AND NON-GENETIC FACTORS ON INR NORMALIZATION IN PRE-OPERATIVE MANAGEMENT OF WARFARIN PATIENTS by ELJILANY, ISLAM AHMED SAYED AHMED

    Published 2021
    “…To optimize the period of preprocedural warfarin interruption to decrease the incidence of bleeding in case of bridging and the incidence of thromboembolism in case of non-bridging, a study was conducted to determine the influence of CYP2C9, VKORC1, CYP4F2, FII, and FVII genetic polymorphisms and non-genetic factors on INR decline in a cohort of Arabs undergoing a procedure that requires warfarin interruption and developing an algorithm to tailor the duration of warfarin interruption before the procedure. …”
    Get full text
  18. 638

    Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey by Turner, Stuart J.

    Published 2013
    “…Univariate sensitivity analysis highlighted that increasing the duration of voriconazole by >1.2 days or decreasing LAmB by >1.0 days changes the result. Monte Carlo Simulation resulted in 69.4% of simulations favouring voriconazole per patient treated.Conclusion: There is a strong likelihood that voriconazole is economically more favourable than LAmB in the empiric treatment of IFI in Turkey.…”
    Get full text
    Get full text
  19. 639
  20. 640